U.S. Life Expectancy Inches Up — Gains Are Fragile and Uneven

Preliminary mortality figures released by the Centers for Disease Control and Prevention in July suggest a modest improvement in U.S. population health: provisional data indicate the U.S. death rate could fall to 689 deaths per 100,000 people in 2025, the lowest recorded since systematic tracking began. At the same time, finalized figures show U.S. life expectancy at birth rose to 79.0 years in 2024, up from 78.4 years in 2023.

On the surface, these shifts signal a rebound from the pandemic years. But public-health researchers warn the headline numbers mask troubling trends and do not necessarily reflect lasting gains in population health.

“This is welcome news, but should be taken with a grain of salt,” said Steven Woolf, MD, professor of family medicine at Virginia Commonwealth University. He noted that the 2025 estimate is only slightly better than 2019 (about 715.2 deaths per 100,000) and that returning to 2019 levels does not mean the country is out of the woods.

Experts highlight several reasons for caution. Recent studies report a sharp rise in excess deaths among people aged 25–44 compared with early-2000s patterns, and childhood mortality has increased as well—trends that imply younger cohorts face greater risks now than previous generations did.

A major international comparison adds perspective: the United States still lags many high-income peers. A JAMA Health Forum study estimated that roughly 46% of U.S. deaths under age 65 would not have occurred if the U.S. experienced the same age-specific death rates as comparable countries—meaning about one in two deaths under 65 may be avoidable.

Why the U.S. Trails Peers

Policy and social-structure differences help explain the gap. Marc Cohen, co-director of the LeadingAge LTSS Center at UMass Boston, notes that many Western European countries invest more in social supports—housing, food access, transportation and other services that prevent illness—while the U.S. spends proportionally more on clinical care.

“European countries tend to invest more in social care and less on acute medical care,” Cohen said. He also warned that recent Medicaid cuts could reverse improvements by reducing access to preventive and chronic-care services for low-income Americans.

Income inequality compounds these issues. Woolf and others emphasize that the longstanding longevity gap between wealthy and poor Americans has widened, and that systemic problems—pollution, uneven access to quality care, and social determinants of health—affect everyone to some extent, even the affluent.

The limits of wealth were illustrated by high-profile longevity efforts, such as those of entrepreneur Bryan Johnson, who reportedly spends millions pursuing antiaging regimens yet still faces health setbacks: Johnson recently disclosed a diagnosis of autoimmune gastritis, a condition that raises the risk of stomach cancer.

What Comes Next

Researchers and public-health leaders say sustained progress will require policy changes that strengthen social supports, expand access to care, and address the root causes of premature mortality. As Woolf put it: “The problem in the United States is not a lack of solutions but a lack of political will.”

Bottom line: The provisional drop in the overall death rate and the small rise in life expectancy are positive signs, but gains are modest, uneven across age groups, and fragile without concrete policy actions to reduce avoidable deaths and narrow persistent inequalities.